Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma

Neurofibromatosis type 2 (NF2) is a tumor suppressor gene syndrome characterized by multiple schwannomas, especially vestibular schwannomas (VS), and meningiomas. Anticancer drug trials are now being explored, but there are no standardized endpoints in NF2. We review the challenges of NF2 clinical t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Plotkin, Scott R., Halpin, Chris, Blakeley, Jaishri O., Slattery, William H., Welling, D. Bradley, Chang, Susan M., Loeffler, Jay S., Harris, Gordon J., Sorensen, A. Gregory, McKenna, Michael J., Barker, Fred G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4036446/
https://ncbi.nlm.nih.gov/pubmed/19430883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-009-9867-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados